Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 737535, 10 pages
http://dx.doi.org/10.1155/2010/737535
Research Article

Depletion of DNMT3A Suppressed Cell Proliferation and Restored PTEN in Hepatocellular Carcinoma Cell

1Key Laboratory of Developmental Genes and Human Diseases, Ministry of Education, Southeast University, Nanjing 210009, China
2Institute of Life Science, Southeast University, Nanjing 210009, China
3Prenatal Diagnosis Center, Nanjing Maternity and Child Health Care Hospital, Nanjing 210009, China

Received 24 November 2009; Revised 25 February 2010; Accepted 26 February 2010

Academic Editor: Mouldy Sioud

Copyright © 2010 Zhujiang Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. Jones, “DNA methylation and cancer,” Oncogene, vol. 21, no. 35, pp. 5358–5360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ehrlich, “DNA methylation in cancer: too much, but also too little,” Oncogene, vol. 21, no. 35, pp. 5400–5413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. T. H. Bestor, “The DNA methyltransferases of mammals,” Human Molecular Genetics, vol. 9, no. 16, pp. 2395–2402, 2000. View at Google Scholar · View at Scopus
  4. M. Okano, S. Xie, and E. Li, “Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases,” Nature Genetics, vol. 19, no. 3, pp. 219–220, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. S. B. Baylin and J. G. Herman, “DNA hypermethylation in tumorigenesis: epigenetics joins genetics,” Trends in Genetics, vol. 16, no. 4, pp. 168–174, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. B. K. Oh, H. Kim, H. J. Park et al., “DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation,” International Journal of Molecular Medicine, vol. 20, no. 1, pp. 65–73, 2007. View at Google Scholar · View at Scopus
  7. H.-J. Park, E. Yu, and Y.-H. Shim, “DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma,” Cancer Letters, vol. 233, no. 2, pp. 271–278, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Choi, Y.-H. Shim, J. Y. Hwa et al., “Expression of DNA methyltransferases in multistep hepatocarcinogenesis,” Human Pathology, vol. 34, no. 1, pp. 11–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Girault, S. Tozlu, R. Lidereau, and I. Bièche, “Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas,” Clinical Cancer Research, vol. 9, no. 12, pp. 4415–4422, 2003. View at Google Scholar · View at Scopus
  10. S. K. Patra, A. Patra, H. Zhao, and R. Dahiya, “DNA methyltransferase and demethylase in human prostate cancer,” Molecular Carcinogenesis, vol. 33, no. 3, pp. 163–171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Eads, K. D. Danenberg, K. Kawakami, L. B. Saltz, P. V. Danenberg, and P. W. Laird, “CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression,” Cancer Research, vol. 59, no. 10, pp. 2302–2306, 1999. View at Google Scholar · View at Scopus
  12. M. Suzuki, N. Sunaga, D. S. Shames, S. Toyooka, A. F. Gazdar, and J. D. Minna, “RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells,” Cancer Research, vol. 64, no. 9, pp. 3137–3143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M.-F. Robert, S. Morin, N. Beaulieu et al., “DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells,” Nature Genetics, vol. 33, no. 1, pp. 61–65, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Okano, D. W. Bell, D. A. Haber, and E. Li, “DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development,” Cell, vol. 99, no. 3, pp. 247–257, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. G.-L. Xu, T. H. Bestor, D. Bourc'his et al., “Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene,” Nature, vol. 402, no. 6758, pp. 187–191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Sowińska and P. P. Jagodzinski, “RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines,” Cancer Letters, vol. 255, no. 1, pp. 153–159, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-C. Chang, C.-Y. Cho, and W.-C. Hung, “Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation,” Cancer Research, vol. 66, no. 17, pp. 8413–8420, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Wang, M. Bhutani, A. K. Pathak et al., “?DNMT3B variants regulate DNA methylation in a promoter-specific manner,” Cancer Research, vol. 67, no. 22, pp. 10647–10652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Kautiainen and P. A. Jones, “DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture,” The Journal of Biological Chemistry, vol. 261, no. 4, pp. 1594–1598, 1986. View at Google Scholar · View at Scopus
  20. K. D. Robertson, E. Uzvolgyi, G. Liang et al., “The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors,” Nucleic Acids Research, vol. 27, no. 11, pp. 2291–2298, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Nagai, A. Nakamura, R. Makino, and K. Mitamura, “Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas,” Hepatology Research, vol. 26, no. 3, pp. 186–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Girault, S. Tozlu, R. Lidereau, and I. Bièche, “Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas,” Clinical Cancer Research, vol. 9, no. 12, pp. 4415–4422, 2003. View at Google Scholar · View at Scopus
  23. M. S. Samuel, H. Suzuki, M. Buchert et al., “Elevated Dnmt3a activity promotes polyposis in ApcMin mice by relaxing extracellular restraints on Wnt signaling,” Gastroenterology, vol. 137, no. 3, pp. 902–913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Shafiei, F. Rahnama, L. Pawella, M. D. Mitchell, P. D. Gluckman, and P. E. Lobie, “DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells,” Oncogene, vol. 27, no. 18, pp. 2602–2612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Yang, M. Guo, J. G. Herman, and D. P. Clark, “Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma,” American Journal of Pathology, vol. 163, no. 3, pp. 1101–1107, 2003. View at Google Scholar · View at Scopus
  26. S. B. Baylin and J. G. Herman, “DNA hypermethylation in tumorigenesis: epigenetics joins genetics,” Trends in Genetics, vol. 16, no. 4, pp. 168–174, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Takai and P. A. Jones, “Comprehensive analysis of CpG islands in human chromosomes 21 and 22,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3740–3745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. P. A. Jones and D. Takai, “The role of DNA methylation in mammalian epigenetics,” Science, vol. 293, no. 5532, pp. 1068–1070, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Roncalli, P. Bianchi, B. Bruni et al., “Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma,” Hepatology, vol. 36, no. 2, pp. 427–432, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Yu, M. Ni, J. Xu et al., “Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis,” BMC Cancer, vol. 2, no. 1, pp. 29–42, 2002. View at Google Scholar · View at Scopus
  31. S. Lee, H. J. Lee, J.-H. Kim, H.-S. Lee, J. J. Jang, and G. H. Kang, “Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis,” American Journal of Pathology, vol. 163, no. 4, pp. 1371–1378, 2003. View at Google Scholar · View at Scopus
  32. B. K. Oh, H. Kim, H. J. Park et al., “DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation,” International Journal of Molecular Medicine, vol. 20, no. 1, pp. 65–73, 2007. View at Google Scholar · View at Scopus
  33. N. Beaulieu, S. Morin, I. C. Chute, M.-F. Robert, H. Nguyen, and A. R. MacLeod, “An essential role for DNA methyltransferase DNMT3B in cancer cell survival,” The Journal of Biological Chemistry, vol. 277, no. 31, pp. 28176–28181, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Hata, M. Okano, H. Lei, and E. Li, “Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice,” Development, vol. 129, no. 8, pp. 1983–1993, 2002. View at Google Scholar · View at Scopus
  35. M. Kaneda, M. Okano, K. Hata et al., “Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting,” Nature, vol. 429, no. 6994, pp. 900–903, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Deng, Y. Kuang, L. Wang, J. Li, Z. Wang, and J. Fei, “An essential role for DNA methyltransferase 3a in melanoma tumorigenesis,” Biochemical and Biophysical Research Communications, vol. 387, no. 3, pp. 611–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Fan, Z. Zhao, Y. Quan, J. Xu, J. Zhang, and W. Xie, “DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721,” European Journal of Gastroenterology and Hepatology, vol. 19, no. 11, pp. 952–961, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Xu, H. Fan, Z.-J. Zhao, J.-Q. Zhang, and W. Xie, “Identification of potential genes regulated by DNA methyltransferase 3B in a hepatocellular carcinoma cell line by RNA interference and microarray analysis,” Yi Chuan Xue Bao, vol. 32, no. 11, pp. 1115–1127, 2005. View at Google Scholar · View at Scopus
  39. L. Wang, W.-L. Wang, Y. Zhang, S.-P. Guo, J. Zhang, and Q.-L. Li, “Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma,” Hepatology Research, vol. 37, no. 5, pp. 389–396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. P. L. M. Dahia, R. C. T. Aguiar, J. Alberta et al., “PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies,” Human Molecular Genetics, vol. 8, no. 2, pp. 185–193, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Goel, T. Nagasaka, C. N. Arnold et al., “The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer,” Gastroenterology, vol. 132, no. 1, pp. 127–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J.-C. Soria, H.-Y. Lee, J. I. Lee et al., “Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation,” Clinical Cancer Research, vol. 8, no. 5, pp. 1178–1184, 2002. View at Google Scholar · View at Scopus
  43. H. B. Salvesen, N. MacDonald, A. Ryan et al., “PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma,” International Journal of Cancer, vol. 91, no. 1, pp. 22–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Salmena, A. Carracedo, and P. P. Pandolfi, “Tenets of PTEN tumor suppression,” Cell, vol. 133, no. 3, pp. 403–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. B. D. Manning and L. C. Cantley, “AKT/PKB signaling: navigating downstream,” Cell, vol. 129, no. 7, pp. 1261–1274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Kim, S. Kim, H. Koh et al., “Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production,” The FASEB Journal, vol. 15, no. 11, pp. 1953–1962, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Shukla, G. T. MacLennan, D. J. Hartman, P. Fu, M. I. Resnick, and S. Gupta, “Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion,” International Journal of Cancer, vol. 121, no. 7, pp. 1424–1432, 2007. View at Publisher · View at Google Scholar · View at Scopus